Literature DB >> 19932102

O-GlcNAcylation enhances FOXO4 transcriptional regulation in response to stress.

Shiuh-Rong Ho1, Kai Wang, Thomas R Whisenhunt, Ping Huang, Xiaolin Zhu, Jeffrey E Kudlow, Andrew J Paterson.   

Abstract

The FOXO4 transcription factor plays an important role in cell survival in response to oxidative stress. The regulation of FOXO4 is orchestrated by post-translational modifications including phosphorylation, acetylation, and ubiquitination. Here, we demonstrate that O-GlcNAcylation also contributes to the FOXO4-dependent oxidative stress response. We show that hydrogen peroxide treatment of HEK293 cells increases FOXO4 association with OGT, the enzyme that adds O-GlcNAc to proteins, causing FOXO4 O-GlcNAcylation and enhanced transcriptional activity under acute oxidative stress. O-GlcNAcylation is known to be protective for cells under stress conditions, including oxidative stress. Our data provide a mechanism of FOXO4 anti-oxidative protection through O-GlcNAcylation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19932102      PMCID: PMC2802345          DOI: 10.1016/j.febslet.2009.11.059

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  27 in total

1.  Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1).

Authors:  P F Dijkers; R H Medema; C Pals; L Banerji; N S Thomas; E W Lam; B M Burgering; J A Raaijmakers; J W Lammers; L Koenderman; P J Coffer
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

2.  Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis.

Authors:  Chad Slawson; Natasha E Zachara; Keith Vosseller; Win D Cheung; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2005-07-18       Impact factor: 5.157

3.  Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin.

Authors:  Zhi-Ping Liu; Zhigao Wang; Hiromi Yanagisawa; Eric N Olson
Journal:  Dev Cell       Date:  2005-08       Impact factor: 12.270

4.  Post-translational modification by O-GlcNAc: another way to change protein function.

Authors:  Jeffrey E Kudlow
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

5.  Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development.

Authors:  Thomas R Whisenhunt; Xiaoyong Yang; Damon B Bowe; Andrew J Paterson; Brian A Van Tine; Jeffrey E Kudlow
Journal:  Glycobiology       Date:  2006-02-27       Impact factor: 4.313

6.  Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.

Authors:  Jia Liu; Yi Pang; Theresa Chang; Pam Bounelis; John C Chatham; Richard B Marchase
Journal:  J Mol Cell Cardiol       Date:  2005-12-09       Impact factor: 5.000

Review 7.  The hexosamine signaling pathway: deciphering the "O-GlcNAc code".

Authors:  Dona C Love; John A Hanover
Journal:  Sci STKE       Date:  2005-11-29

8.  Discovery of O-GlcNAc transferase inhibitors.

Authors:  Benjamin J Gross; Brian C Kraybill; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2005-10-26       Impact factor: 15.419

9.  Age-dependent FOXO regulation of p27Kip1 expression via a conserved binding motif in rat muscle precursor cells.

Authors:  Simon J Lees; Tom E Childs; Frank W Booth
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-11       Impact factor: 4.249

10.  Mdm2 induces mono-ubiquitination of FOXO4.

Authors:  Arjan B Brenkman; Peter L J de Keizer; Niels J F van den Broek; A G Jochemsen; Boudewijn M Th Burgering
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more
  10 in total

Review 1.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

Review 2.  Functional crosstalk among oxidative stress and O-GlcNAc signaling pathways.

Authors:  Po-Han Chen; Jen-Tsan Chi; Michael Boyce
Journal:  Glycobiology       Date:  2018-08-01       Impact factor: 4.313

Review 3.  O-GlcNAc signalling: implications for cancer cell biology.

Authors:  Chad Slawson; Gerald W Hart
Journal:  Nat Rev Cancer       Date:  2011-08-18       Impact factor: 60.716

Review 4.  The FOXO family of transcription factors: key molecular players in gastric cancer.

Authors:  Ying Liu; Xiang Ao; Yi Jia; Xiaoge Li; Yu Wang; Jianxun Wang
Journal:  J Mol Med (Berl)       Date:  2022-06-10       Impact factor: 5.606

Review 5.  Molecular Functions of Glycoconjugates in Autophagy.

Authors:  Kamau Fahie; Natasha E Zachara
Journal:  J Mol Biol       Date:  2016-06-23       Impact factor: 5.469

6.  O-GlcNAcylation enhances anaplastic thyroid carcinoma malignancy.

Authors:  Y U Cheng; Honglun Li; Jianlin Li; Jisheng Li; Yan Gao; Baodong Liu
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

7.  Computational identification and modeling of crosstalk between phosphorylation, O-β-glycosylation and methylation of FoxO3 and implications for cancer therapeutics.

Authors:  Azeem Mehmood Butt; Dandan Feng; Muhammad Idrees; Yigang Tong; Jun Lu
Journal:  Int J Mol Sci       Date:  2012-03-05       Impact factor: 6.208

8.  Senescence-related changes in gene expression of peripheral blood mononuclear cells from octo/nonagenarians compared to their offspring.

Authors:  Amirah Abdul Rahman; Norwahidah Abdul Karim; Noor Aini Abdul Hamid; Roslan Harun; Wan Zurinah Wan Ngah
Journal:  Oxid Med Cell Longev       Date:  2013-11-27       Impact factor: 6.543

Review 9.  Elucidating the Possible Role of FoxO in Depression.

Authors:  Tarapati Rana; Tapan Behl; Aayush Sehgal; Vineet Mehta; Sukhbir Singh; Neelam Sharma; Simona Bungau
Journal:  Neurochem Res       Date:  2021-06-01       Impact factor: 3.996

10.  Influence of glucosamine on the bioactivity of insulin delivered subcutaneously and in an oral nanodelivery system.

Authors:  Zakieh I Al-Kurdi; Babur Z Chowdhry; Stephen A Leharne; Nidal A Qinna; Mahmoud M H Al Omari; Adnan A Badwan
Journal:  Drug Des Devel Ther       Date:  2015-11-19       Impact factor: 4.162

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.